Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 16, 2018 - Issue 8
Submit an article Journal homepage
1,434
Views
1
CrossRef citations to date
0
Altmetric
Editorial

The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C

Luigi Elio AdinolfiDepartment of Medical, Surgical, Neurological, Metabolic, and Geriatric Sciences, University of Campania ‘L. Vanvitelli, Naples, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8453-4912View further author information
ORCID Icon,
Luca RinaldiDepartment of Medical, Surgical, Neurological, Metabolic, and Geriatric Sciences, University of Campania ‘L. Vanvitelli, Naples, ItalyView further author information
,
Aldo MarroneDepartment of Medical, Surgical, Neurological, Metabolic, and Geriatric Sciences, University of Campania ‘L. Vanvitelli, Naples, ItalyView further author information
&
Mauro GiordanoDepartment of Medical, Surgical, Neurological, Metabolic, and Geriatric Sciences, University of Campania ‘L. Vanvitelli, Naples, ItalyView further author information
Pages 595-597 | Received 06 Mar 2018, Accepted 24 Jul 2018, Published online: 01 Aug 2018

References

  • Adinolfi LE, Restivo L, Zampino R, et al. Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opin Pharmacother. 2011;12:2215–2234.
  • Lonardo A, Adinolfi LE, Petta S, et al. Hepatitis C and diabetes: the inevitable coincidence? Expert Review Anti-Infect Ther. 2009;7:239–308.
  • Miyamoto H, Moriishi K, Moriya K, et al. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol. 2007;81:1727–1735.
  • Masini M, Campani D, Boggi U, et al. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care. 2005;28:940–941.
  • Aytug S, Reich D, Sapiro LE, et al. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology. 2005;38:1384–1392.
  • Pandya P, Pant C, Taylor R, et al. Impact of sustained virological response to chronic hepatitic C antiviral therapy on new onset diabetes mellitus type 2 after controlling for metabolic syndrome. J Investig Med. 2017;65:765–771.
  • Adinolfi LE, Nevola R, Guerrera B, et al. HCV clearance by direct-acting antiviral treatment and impact on insulin resistance in chronic hepatitis C. J Gastroenterol Hepatol. 2018;33:1379–1382.
  • Li J, Zhang T, Gordon SC, et al. Impact of sustained virological response on incidence of type 2 diabetes in hepatitis C patients. Hepatology. 2017;66:531A.
  • Hum J, Jou JH, Green PK, et al. Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis C virus. Diabetes Care. 2017;40:1173–1180.
  • Ciancio A, Bosio R, Bo S, et al. Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents. J Med Virol. 2018;90:320–327.
  • Dawood AA, Nooh MZ, Elgamal AA. Factors associated with improved glycemic control by direct-acting antiviral agent treatment in Egyptian type 2 diabetes mellitus patients with chronic hepatitis C genotype 4. Diabetes Metab J. 2017;41:316–321.
  • Pavone P, Tieghi T, d’Ettorre G, et al. Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents. Clin Microbiol Infect. 2016;22:462.e1–462.e3.
  • Morales AL, Junga Z, Singla MB, et al. Hepatitis C eradication with sofosbuvir leads to significant metabolic changes. World J Hepatol. 2016;8:1557–1563.
  • Fabrizio C, Procopio A, Scudeller L, et al. HCV and diabetes: towards a ‘sustained’ glycaemic improvement after treatment with DAAs? Clin Microbiol Infect. 2017;23:342–343.
  • Abdel Alem S, Elsharkawy A, Fouad R, et al. Improvement of glycemic state among responders to sofosbuvir-based treatment regimens: single center experience. J Med Virol. 2017;89:2181–2187.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.